BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

550 related articles for article (PubMed ID: 31046810)

  • 21. Dalbavancin as an option for treatment of S. aureus bacteremia (DOTS): study protocol for a phase 2b, multicenter, randomized, open-label clinical trial.
    Turner NA; Zaharoff S; King H; Evans S; Hamasaki T; Lodise T; Ghazaryan V; Beresnev T; Riccobene T; Patel R; Doernberg SB; Rappo U; Fowler VG; Holland TL;
    Trials; 2022 May; 23(1):407. PubMed ID: 35578360
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Healthcare Improvement Intervention Combining Nucleic Acid Microarray Testing With Direct Physician Response for Management of Staphylococcus aureus Bacteremia.
    Eby JC; Richey MM; Platts-Mills JA; Mathers AJ; Novicoff WM; Cox HL
    Clin Infect Dis; 2018 Jan; 66(1):64-71. PubMed ID: 29020181
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Staphylococcus aureus bacteraemia--Nationwide assessment of treatment adequacy and outcome.
    Asgeirsson H; Kristjansson M; Kristinsson KG; Gudlaugsson O
    J Infect; 2011 May; 62(5):339-46. PubMed ID: 21402101
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of echocardiography in uncomplicated Staphylococcus aureus catheter-related bloodstream infections.
    Mun SJ; Kim SH; Huh K; Cho SY; Kang CI; Chung DR; Peck KR
    Medicine (Baltimore); 2021 May; 100(18):e25679. PubMed ID: 33950948
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of C-Reactive Protein-Guided Antibiotic Treatment Duration, 7-Day Treatment, or 14-Day Treatment on 30-Day Clinical Failure Rate in Patients With Uncomplicated Gram-Negative Bacteremia: A Randomized Clinical Trial.
    von Dach E; Albrich WC; Brunel AS; Prendki V; Cuvelier C; Flury D; Gayet-Ageron A; Huttner B; Kohler P; Lemmenmeier E; McCallin S; Rossel A; Harbarth S; Kaiser L; Bochud PY; Huttner A
    JAMA; 2020 Jun; 323(21):2160-2169. PubMed ID: 32484534
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Utility of Risk Factors to Define Complicated Staphylococcus aureus Bacteremia in a Setting With Low Methicillin-Resistant S. aureus Prevalence.
    van der Vaart TW; Prins JM; Goorhuis A; Lemkes BA; Sigaloff KCE; Spoorenberg V; Stijnis C; Bonten MJM; van der Meer JTM
    Clin Infect Dis; 2024 Apr; 78(4):846-854. PubMed ID: 38157401
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Complete adherence to evidence-based quality-of-care indicators for Staphylococcus aureus bacteremia resulted in better prognosis.
    Nagao M; Yamamoto M; Matsumura Y; Yokota I; Takakura S; Teramukai S; Ichiyama S
    Infection; 2017 Feb; 45(1):83-91. PubMed ID: 27709434
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mortality predictors of Staphylococcus aureus bacteremia: a prospective multicenter study.
    Yilmaz M; Elaldi N; Balkan İİ; Arslan F; Batırel AA; Bakıcı MZ; Gozel MG; Alkan S; Çelik AD; Yetkin MA; Bodur H; Sınırtaş M; Akalın H; Altay FA; Şencan İ; Azak E; Gündeş S; Ceylan B; Öztürk R; Leblebicioglu H; Vahaboglu H; Mert A
    Ann Clin Microbiol Antimicrob; 2016 Feb; 15():7. PubMed ID: 26860463
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Prospective Cohort Study of Durations of
    Kang CK; Song KH; Kim SE; Kim ES; Park WB; Park KH; Chun SH; Lee S; Cho CR; Kang SJ; Oh MD; Kim YS; Lee SH; Kwak YG; Jang HC; Kim CJ; Kim YK; Bang JH; Kiem S; Kwon KT; Jung Y; Kang YM; Jung SI; Kim HB;
    Antimicrob Agents Chemother; 2019 Dec; 64(1):. PubMed ID: 31636069
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of comorbidity in mortality related to Staphylococcus aureus bacteremia: a prospective study using the Charlson weighted index of comorbidity.
    Lesens O; Methlin C; Hansmann Y; Remy V; Martinot M; Bergin C; Meyer P; Christmann D
    Infect Control Hosp Epidemiol; 2003 Dec; 24(12):890-6. PubMed ID: 14700403
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sequential oral antibiotic in uncomplicated Staphylococcus aureus bacteraemia: a propensity-matched cohort analysis.
    Diego-Yagüe I; Mora-Vargas A; Vázquez-Comendador JM; Santamarina-Alcantud B; Fernández-Cruz A; Múñez-Rubio E; Gutiérrez-Villanueva A; Sanchez-Romero I; Moreno-Torres V; Ramos-Martínez A; Calderón-Parra J
    Clin Microbiol Infect; 2023 Jun; 29(6):744-750. PubMed ID: 36773773
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management and outcomes in patients with Staphylococcus aureus bacteremia after implementation of mandatory infectious diseases consult: a before/after study.
    Martin L; Harris MT; Brooks A; Main C; Mertz D
    BMC Infect Dis; 2015 Dec; 15():568. PubMed ID: 26666459
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ceftobiprole versus daptomycin in
    Hamed K; Engelhardt M; Jones ME; Saulay M; Holland TL; Seifert H; Fowler VG
    Future Microbiol; 2020 Jan; 15(1):35-48. PubMed ID: 31918579
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An Automated, Pharmacist-Driven Initiative Improves Quality of Care for Staphylococcus aureus Bacteremia.
    Wenzler E; Wang F; Goff DA; Prier B; Mellett J; Mangino JE; Bauer KA
    Clin Infect Dis; 2017 Jul; 65(2):194-200. PubMed ID: 28379326
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Study on the utility of a statewide counselling programme for improving mortality outcomes of patients with
    Weis S; Hagel S; Schmitz RP; Scherag A; Brunkhorst FM; Forstner C; Löffler B; Pletz MW
    BMJ Open; 2017 Apr; 7(4):e013976. PubMed ID: 28391236
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Echocardiography is dispensable in uncomplicated Staphylococcus aureus bacteremia.
    Khatib R; Sharma M
    Medicine (Baltimore); 2013 May; 92(3):182-188. PubMed ID: 23619238
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management of patients with Staphylococcus aureus bacteraemia in a university hospital: a retrospective study.
    Verhagen DW; van der Meer JT; Hamming T; de Jong MD; Speelman P
    Scand J Infect Dis; 2003; 35(8):459-63. PubMed ID: 14514144
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Epidemiology, course and prognosis of Staphylococcus aureus bacteremia--Preliminary results from the INSTINCT (INvasive STaphylococcus aureus INfection CohorT) cohort].
    Seifert H; Wisplinghoff H; Kaasch A; Achilles K; Langhorst A; Peyerl-Hoffmann G; Woehrmann A; Fätkenheuer G; Salzberger B; Kern WV
    Dtsch Med Wochenschr; 2008 Feb; 133(8):340-5. PubMed ID: 18270913
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of HLA-DRA and CD74 mRNA in whole blood during the course of complicated and uncomplicated Staphylococcus aureus bacteremia.
    Rasmussen G; Cajander S; Bäckman A; Källman J; Söderquist B; Strålin K
    Microbiol Immunol; 2017 Oct; 61(10):442-451. PubMed ID: 28862321
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improved outcome with early rifampicin combination treatment in methicillin-sensitive Staphylococcus aureus bacteraemia with a deep infection focus - a retrospective cohort study.
    Forsblom E; Ruotsalainen E; Järvinen A
    PLoS One; 2015; 10(4):e0122824. PubMed ID: 25874546
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.